Jeffrey Low, MD

Jeffrey Low, MD, is a prominent figure in the field of life sciences and healthcare investment, currently serving as a Board Member at Verana Health. He is also a Principal at Novo Growth, where he focuses on venture capital and growth equity investments in the healthcare sector. Dr. Low has a robust background in supporting early and growth-stage companies, particularly in digital health and medical research.

Education and Background

Dr. Low holds a medical degree (MD) and an MBA, which equips him with both clinical and business acumen. His educational background includes training at Yale University School of Medicine, which adds to his expertise in life sciences.234

Role at Verana Health

At Verana Health, Dr. Low is involved in leveraging real-world data to enhance medical research and improve patient outcomes. He joined the company's Board of Directors around January 2022, coinciding with a significant funding round that aimed to expand Verana's capabilities in delivering quality insights across the drug lifecycle.12 His contributions are pivotal in shaping the strategic direction of the company as it collaborates with leading pharmaceutical firms and medical societies.1

Professional Focus

Dr. Low is particularly interested in how technology can transform healthcare delivery and research. His work at Verana Health emphasizes the importance of high-quality data derived from electronic health records to support clinical trials and inform research outcomes.12

Through his role, he aims to foster innovations that ultimately enhance the quality of life for patients by improving healthcare practices and accelerating the development of new therapies.

In summary, Jeffrey Low, MD, is a key player in advancing digital health initiatives through his strategic role at Verana Health and his broader work in healthcare investment.